Suraksha Diagnostic IPO

Suraksha Diagnostic IPO opens for subscription on November 29, 2024 and closes on December 3, 2024. The allotment for the Suraksha Diagnostic IPO is expected to be finalized on Wednesday, December 4, 2024. Suraksha Diagnostic IPO will list on BSE, NSE with tentative listing date fixed as Friday, December 6, 2024.

Suraksha Diagnostic IPO price band is set at ₹420 to ₹441 per share. The minimum lot size for an application is 34 Shares. The minimum amount of investment required by retail investors is ₹14,994. The minimum lot size investment for sNII is 14 lots (476 shares), amounting to ₹209,916, and for bNII, it is 67 lots (2,278 shares), amounting to ₹1,004,598.

Suraksha Diagnostic IPO is a book built issue of Rs 846.25 crores. The issue is entirely an offer for sale of 1.92 crore shares.

Suraksha Diagnostic IPO Details

Suraksha Diagnostic IPO Lot Size

Investors can bid for a minimum of 34 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Suraksha Diagnostic IPO Objectives

The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.

About Suraksha Diagnostic 

Incorporated in 2005, Suraksha Diagnostic offers pathology, radiology testing and medical consultancy services. The company has a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres as of June 30, 2024, across West Bengal, Bihar, Assam, and Meghalaya.

The company offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors.

The operation of the diagnostic centres is supported by the technology platforms and systems that the company uses to streamline, such as its Laboratory Information Management System (“LIMS”), its fully integrated Radiology Information System (“RIS”), its Picture Archive Communication System (“PACS”) and its Enterprise Resource Planning System (“ERP”).

The company offers vaccination services and customized testing packages for disease prediction/early detection. The company uses digital pathology and artificial intelligence to generate blood tests. All radiology reporting is done through a digital platform that allows cases to be reported from all diagnostic centres, significantly reducing turnaround time.

Competitive Strengths are:

Management team with relevant industry experience.

Well-positioned diagnostics chain to capture the large growth opportunities for organized diagnostics chains in the fragmented markets for diagnostic services in eastern and northeastern India.

Integrated diagnostics provider offering pathology and radiology testing and medical consultancy services from a single source.

Well-invested and technologically advanced clinical infrastructure.

Commitment to quality driving high individual consumer business share and customer retention.

Suraksha Diagnostic Financial Information

Suraksha Diagnostic IPO Reservation

Suraksha Diagnostic IPO Timeline (Tentative Schedule)

Suraksha Diagnostic IPO opens on November 29, 2024, and closes on December 3, 2024.